Belite Bio Prices $350 Million Equity Offering

MT Newswires Live
12/02

Belite Bio (BLTE) said Monday it has priced an underwritten public offering of about 2.3 million American depositary shares at $154 each.

The company said it has also granted underwriters a 30-day option to purchase up to 340,909 additional depositary shares.

The company said it expects gross proceeds of about $350 million from the offering, which is expected to close about Wednesday.

The company said it plans to use net proceeds of the offering for general corporate purposes.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10